基本信息
views: 0
Career Trajectory
Bio
Claudio Vernieri, M.D. Ph.D., specialized in Clinical Oncology and Cancer Metabolism.
Since January 2020 he directs the Metabolic Reprogramming in Solid Tumors program at IFOM, and works as a medical oncologist in the Breast Unit of Fondazione IRCCS Istituto Nazionale dei Tumori.
He was born in 1984, Naples (Italy). In 2008 he graduated with honors in Medicine and Surgery at the University Federico II of Naples. In 2014 he obtained his PhD in Molecular Medicine (Human Genetics and Molecular Oncology) in Andrea Ciliberto’s Lab in IFOM, where he studied mechanisms of eukaryotic cell adaptation to prolonged cell cycle arrest in mitosis and Spindle Assembly Checkpoint (SAC) activation.
During his PhD studies, Dr. Vernieri found that the phosphorylation of Anaphase Promoting Complex (APC) subunits by Cyclin-Dependent Kinase 1 (CDK1) are essential for eukaryotic cell adaptation to the SAC, while the Protein Phosphatase 2A (PP2A) reverses CDK1-induced phosphorylation of the APC, thus delaying the onset of cell adaptation.
In 2014 Dr. Vernieri moved to the Fondazione IRCCS Istituto Nazionale dei Tumori (INT) di Milano (Italy) for his residency in Medical Oncology under the supervision Prof. Filippo de Braud’s group. There, he focused on clinical and translational research activities on cancer metabolism and breast cancer, giving an important contribution to the design and conduction of independent clinical trials aimed at assessing the safety, feasibility and anticancer activity of specific metabolic interventions, such as calorie restricted diets and metformin, in different cancer patient populations.
Since December 2019 Dr. Vernieri is a Specialist in Medical Oncology, and in January 2020 he has been recruited at IFOM to start an independent research group focused on the study of metabolic reprogramming in solid tumors.
Research Interests
Papers共 147 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer Researchno. 9_Supplement (2024): RF02-07
crossref(2024)
crossref(2024)
crossref(2024)
Journal of Clinical Oncologyno. 16_suppl (2024): 1032-1032
Cancer Researchno. 9_Supplement (2024): PO1-03
Federica Miglietta,Claudio Vernieri, Manon de Graaf, Fabio Secomandi,Matilde Cacciatore,Andrea Botticelli,Andrea Vingiani,Giuseppe Fotia,Gaia Griguolo,Tommaso Giarratano, Valerio Pellegrini,Daniela Iannaccone,
Journal of Clinical Oncologyno. 16_suppl (2024): 1100-1100
Cancer (2024)
Chiara Listorti,Annalisa Curcio,Claudio Vernieri,Francesco Barretta, Pierfrancesco Cadenelli, Chiara Osio,Cristina Ferraris,Ilaria Maugeri,Federica Pilotta,Massimiliano Gennaro, Marco Visaggio,Giulia Bianchi,
European Journal of Surgical Oncologyno. 2 (2024): 107527
Marzia Santamaria, Beatrice Cantarelli,Arta Ajazi, Chiara Milanese,Giulia Salvadori,Pier Giorgio Mastroberardino,Paola Antonia Corsetto,Giancarlo Pruneri,Filippo De Braud,Claudio Vernieri
CANCER RESEARCHno. 7 (2024)
Load More
Author Statistics
#Papers: 148
#Citation: 2144
H-Index: 24
G-Index: 45
Sociability: 7
Diversity: 3
Activity: 179
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn